Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study

被引:170
|
作者
Wan, Emily S. [1 ,2 ]
Fortis, Spyridon [3 ]
Regan, Elizabeth A. [4 ]
Hokanson, John [5 ]
Han, MeiLan K. [6 ]
Casaburi, Richard [7 ]
Make, Barry J. [4 ]
Crapo, James D. [4 ]
DeMeo, Dawn L. [1 ]
Silverman, Edwin K. [1 ]
机构
[1] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA
[2] VA Boston Healthcare Syst, Pulm & Crit Care Sect, Boston, MA USA
[3] Univ Iowa, Dept Pulm Crit Care & Occupat Med, Iowa City, IA USA
[4] Natl Jewish Hlth, Denver, CO USA
[5] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Denver, CO 80202 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Rehabil Clin Trials Ctr, Torrance, CA 90509 USA
关键词
spirometry classification; spirometry statistics and numerical data; spirometry mortality; lung disease epidemiology; OBSTRUCTIVE PULMONARY-DISEASE; NUTRITION EXAMINATION SURVEY; LOW LUNG-FUNCTION; RESPIRATORY SYMPTOMS; NATIONAL-HEALTH; FOLLOW-UP; UNITED-STATES; PREVALENCE; SMOKING; POPULATION;
D O I
10.1164/rccm.201804-0663OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Increasing awareness of the prevalence and significance of Preserved Ratio Impaired Spirometry (PRISm), alternatively known as restrictive or Global Initiative for Chronic Obstructive Lung Disease (GOLD)-unclassified spirometry, has expanded the body of knowledge on cross-sectional risk factors. However, longitudinal studies of PRISm remain limited. Objectives: To examine longitudinal patterns of change in lung function, radiographic characteristics, and mortality of current and former smokers with PRISm. Methods: Current and former smokers, aged 45 to 80 years, were enrolled in COPDGene (phase 1, 2008-2011) and returned for a 5-year follow-up (phase 2, 2012-2016). Subjects completed questionnaires, spirometry, chest computed tomography scans, and 6-minute-walk tests at both study visits. Baseline characteristics, longitudinal change in lung function, and mortality were assessed by post-bronchodilator lung function categories: PRISm (FEV1/FVC < 0.7 and FEV1 < 80%), GOLD0 (FEV1/FVC > 0.7 and FEV1 > 80%), and GOLD1-4 (FEV1/FVC < 0.7). Measurements and Main Results: Although the prevalence of PRISm was consistent (12.4-12.5%) at phases 1 and 2, subjects with PRISm exhibited substantial rates of transition to and from other lung function categories. Among subjects with PRISm at phase 1, 22.2% transitioned to GOLD0 and 25.1% progressed to GOLD1-4 at phase 2. Subjects with PRISm at both phase 1 and phase 2 had reduced rates of FEV(1 )decline (-27.3 -+/- 42.1 vs. -33.0 +/- 41.7 ml/yr) and comparable proportions of normal computed tomography scans (51% vs. 52.7%) relative to subjects with stable GOLD0 spirometry. In contrast, incident PRISm exhibited accelerated rates of lung function decline. Subjects with PRISm at phase 1 had higher mortality rates relative to GOLD0 and lower rates relative to the GOLD1-4 group. Conclusions: PRISm is highly prevalent, is associated with increased mortality, and represents a transitional state for significant subgroups of subjects. Additional studies to characterize longitudinal progression in PRISm are warranted.
引用
收藏
页码:1397 / 1405
页数:9
相关论文
共 50 条
  • [1] Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study (vol 198, pg 1397, 2018)
    Wan, E. S.
    Fortis, S.
    Regan, E. A.
    Hokanson, J.
    Han, M. K.
    Casaburi, R.
    Make, B. J.
    Crapo, J. D.
    Demeo, D. L.
    Silverman, E. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (07) : 824 - 824
  • [2] Longitudinal Lung Function And Mortality In Preserved Ratio Impaired Spirometry ( prism) In The COPDgene Study
    Wan, E. S.
    Fortis, S.
    Hokanson, J.
    DeMeo, D. L.
    Crapo, J. D.
    Silverman, E. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene
    Wan, Emily S.
    Castaldi, Peter J.
    Cho, Michael H.
    Hokanson, John E.
    Regan, Elizabeth A.
    Make, Barry J.
    Beaty, Terri H.
    Han, MeiLan K.
    Curtis, Jeffrey L.
    Curran-Everett, Douglas
    Lynch, David A.
    DeMeo, Dawn L.
    Crapo, James D.
    Silverman, Edwin K.
    RESPIRATORY RESEARCH, 2014, 15
  • [4] Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene
    Emily S Wan
    Peter J Castaldi
    Michael H Cho
    John E Hokanson
    Elizabeth A Regan
    Barry J Make
    Terri H Beaty
    MeiLan K Han
    Jeffrey L Curtis
    Douglas Curran-Everett
    David A Lynch
    Dawn L DeMeo
    James D Crapo
    Edwin K Silverman
    Respiratory Research, 15
  • [5] Diabetes and Cardiovascular Mortality Among Restrictive and Preserved Ratio Impaired Spirometry Phenotypes
    Lahousse, Lies
    CHEST, 2025, 167 (02) : 314 - 315
  • [6] Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study
    Wijnant, Sara Renata Alex
    De Roos, Emmely
    Kavousi, Maryam
    Stricker, Bruno Hugo
    Terzikhan, Natalie
    Lahousse, Lies
    Brusselle, Guy G.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (01)
  • [7] Preserved Ratio Impaired Spirometry (PRISm) and mortality: the Rotterdam Study
    Wijnant, Sara
    De Roos, Emmely
    Kavousi, Maryam
    Stricker, Bruno
    Terzikhan, Natalie
    Lahousse, Lies
    Brusselle, Guy
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] Association of Preserved Ratio Impaired Spirometry (PRISm) with All-Cause Mortality: a longitudinal cohort study
    Im, Yunjoo
    Kim, Taeyun
    Park, Hye Yun
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [9] Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort
    Sooim Sin
    Eun Ju Lee
    Sungho Won
    Woo Jin Kim
    BMC Pulmonary Medicine, 23
  • [10] Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort
    Sin, Sooim
    Lee, Eun Ju
    Won, Sungho
    Kim, Woo Jin
    BMC PULMONARY MEDICINE, 2023, 23 (01)